MILADY: A Randomized, Placebo-controlled Safety and Efficacy Trial of SSR240600C in Treatment of Overactive Bladder or Urge Urinary Incontinence.

PHASE2CompletedINTERVENTIONAL
Enrollment

118

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

May 31, 2006

Study Completion Date

May 31, 2006

Conditions
Overactive Bladder
Interventions
DRUG

SSR240600C

once daily

DRUG

Placebo

oral

DRUG

Tolterodine

once daily

Trial Locations (22)

12401

Hudson Valley Urology Center, Kingston

12601

Hudson Valley Urology, Poughkeepsie

15206

Clinical Trials Research Services, Pittsburgh

19114

Philadelphia Women's Research, Philadelphia

30005

Atlanta Women's Research Institute, Alpharetta

30034

Soapstone Center for Education & Clinical Research, Decatur

30328

Mount Vernon Clinical Research, Atlanta

32308

Southeastern Research Group, Tallahassee

33143

Miami Research Associates, Miami

46143

Urology of Indiana, Greenwood

47130

Metropolitan Urology, Jeffersonville

53209

Midwest Research SpecialistsSt. Michael's Hospital, Milwaukee

64131

Rockhill Medical Plaza, Kansas City

78414

Advanced Research Associates, Corpus Christi

80220

Genitourinary Surgical Consultants, Denver

85032

Hope Research LLC, Phoenix

85712

Research Tuscon, Tuscon

92108

Medical Center for Clinical Research, San Diego

97504

Daniel Laury, Medford

98405

Tacoma Women's Specialists Research, Tacoma

06708

Connecticut Clinical Research Center, Urology Specialists, Waterbury

02904

University Urological Research Institute, Providence

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sanofi

INDUSTRY